Cookies: Information & Consent

We have placed cookies on your device to help make this website better. Some of the cookies we use are essential for this site to work. We also use some non-essential cookies to collect information for making reports and to help us improve the site. You will find more detailled information in our Privacy Chart.

March 2020

Banook Group welcomes Turenne Santé as new investor, alongside the management

Funds obtained will enable the European leader in cardiac safety to continue its…
Read the full post
May 2018

Webinar : Advances in cardiovascular diagnostic devices for clinical trial

Tuesday, May 29th, 2018  6:00 PM CEST (Central European Time) UTC/GMT + 2…
Read the full post
April 2017

Event Participation 2017

Banook Group will attend the following exhibitions. Let’s meet there!
Read the full post
February 2017

Cardiabase by Banook Group opens subsidiary in Montreal, Canada

Group strengthens its presence in North American market, aiming for 30% growth in…
Read the full post
March 2015

Banook Group - New branding announcement

Cardiabase/Banook Central Imaging becomes Banook Group - New branding announcement.
Read the full post
March 2014

Webinar: Imaging anti-cancer treatment response at a preclinical and clinical stage

Use of imaging in oncology clinical trials is mainly based on morphological evaluation…
Read the full post
Mission & strategy > Why choose Banook Group partner?

Why choose Banook Group as partner?


The Banook Group offers the infrastructure, team, experience and commitment to bring your clinical trials to a successful

completion on time and on budget, while ensuring the delivery of high quality data at a competitive cost.


Our top five strengths 



Responsiveness and availability Responsiveness and availability


When you work with the Banook Group you are guaranteed a close collaborative relationship between your and our teams with close and rapid access to highly experienced staff so that you can plan and conduct your project in the most rapid faster and efficient manner.


We :

  • rapidly respond to issue and routine calls,
  • rapidly provide scientific expertise,
  • rapidly adjust to specific protocol requirement,
  • rapidly mobilize “within the scope reviewers”,
  • rapidly deploy an operational team for setting up a new project,
  • rapidly address issues during study conduct, and
  • provide the agreed-upon deliverables in a short-time frame.


A unique range of services  A unique range of services


The Banook Group is one of the very few providers with the necessary expertise and capabilities to offer services in the following important areas of drug development:


  • From single center, early phase to multicenter, late phase trials,
  • In a broad range of therapeutics areas: allergy, cardiology, CNS, dermatology endocrinology, gastroenterology, hematology, immunology, infectious disease, medical devices, metabolic disease, musculoskeletal, nephrology, neurology, oncology, pulmonary/respiratory, renal disease, rheumatology, urology.

Cardiac Safety, Central Imaging, Endpoint Adjudication.

Quality and timelines  Quality and timelines



The Banook Group is committed to providing you with innovative and reliable solutions. This approach helps you optimize your decision-making process and reduce costs, while rigorously adhering to good clinical practices and comply with international regulatory requirements:


  • A Quality commitment charter,
  • A dedicated Quality department,
  • Quality-centered data processing tools,
  • Compliance with FDA-XML file standards,
  • On time and on budget deliverables.


Global coverage Global coverage


The Banook Group is present on all 5 continents, including emerging countries.


  • 8 000+ sites in 75 countries,
  • Headquarters in Europe and United States,
  • 24-7-365 technical helpdesk and team members fluent in english, french and spanish,
  • Data reports issued within 24/48/72h*, 7 days a week,
  • Site training in French, English and Spanish**.


* Other timelines available

**Other languages can be provided on request


A family-owned, independant company A family-owned, independant company


  • Family owned company, founded in 1999 by Pascal and Martine Voiriot, with exclusive organic growth,
  • Financially stable and strong, without any risk of disruptive merger or acquisition,
  • Long-term focus,
  • Commitment to quality: long-term business relationships and partnerships,
  • Long-term investments in equipment, infrastructure and personnel,
  • Stable, experienced staff with very low turnover (~5% per year; none for management).

A family-owned, independant company